Croatian Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 1 - 20 out of 48 displayed.
1 2 3 »

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 06 Jul 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 29 Jun 2020

Rybelsus® approved in Japan for the treatment of type 2 diabetes

Read more ››

By: GlobenewsWire - 29 Jun 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 22 Jun 2020

Novo Nordisk successfully completes AM833 phase 2 trial and phase 1 combination trial with AM833 and semaglutide in obesity

Read more ››

By: GlobenewsWire - 18 Jun 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 15 Jun 2020

Semaglutide 2.4 mg shows superior weight loss versus placebo in the phase 3 trials STEP 2 and STEP 3, thereby successfully completing the programme

Read more ››

By: GlobenewsWire - 12 Jun 2020

Novo Nordisk reports weight loss of 14.9% (16.9% if taken as intended) in STEP 1 trial

Read more ››

By: GlobenewsWire - 04 Jun 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 03 Jun 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 25 May 2020

Semaglutide 2.4 mg demonstrates superior and sustained weight loss versus placebo and in addition a 17.4% weight loss after 68 weeks in STEP 4 trial

Read more ››

By: GlobenewsWire - 13 May 2020

Trading in Novo Nordisk shares by board members, executives and associated persons on 11 May 2020

Read more ››

By: GlobenewsWire - 12 May 2020

Novo Nordisk A/S purchases B shares worth DKK 3,051 million from Novo Holdings A/S under the 2020 share repurchase programme

Read more ››

By: GlobenewsWire - 11 May 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 11 May 2020

Trading in Novo Nordisk shares by board members, executives and associated persons on 11 May 2020

Read more ››

By: GlobenewsWire - 11 May 2020

Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2020

Read more ››

By: GlobenewsWire - 11 May 2020

Novo Nordisk's sales increased by 16% in Danish kroner and by 14% at constant exchange rates (CER) to DKK 33.9 billion in the first three months of 2020

Read more ››

By: GlobenewsWire - 06 May 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 05 May 2020

Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 30 April 2020

Read more ››

By: GlobenewsWire - 30 Apr 2020

Novo Nordisk A/S – Reduction of the share capital

Read more ››

By: GlobenewsWire - 28 Apr 2020

Looking for companies outside of Croatia?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

July 2020
- Digital Novel Coronavirus Investment Forum Empowering Early
- Florida: Evolution Summit
- Taipei: BIO Asia-Taiwan

Add an Event »

Latest company news

There are currently no news available for this portal

Visit the global news page on Biotechgate »

Biotechgate database

About Biotechgate
The Croatian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com